Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance

Glioblastoma (GBM) is the most malignant and lethal brain tumor. Current standard treatment consists of surgery followed by radiotherapy/chemotherapy; however, this is only a palliative approach with a mean post-operative survival of scarcely ~12–15 months. Thus, the identification of novel therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuentes-Fayos, Antonio C., G-García, Miguel E., Pérez-Gómez, Jesús M., Peel, Annabel, Blanco-Acevedo, Cristóbal, Solivera, Juan, Ibáñez-Costa, Alejandro, Gahete, Manuel D., Castaño, Justo P., Luque, Raúl M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835306/
https://www.ncbi.nlm.nih.gov/pubmed/35163067
http://dx.doi.org/10.3390/ijms23031143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835306/
https://www.ncbi.nlm.nih.gov/pubmed/35163067
http://dx.doi.org/10.3390/ijms23031143

Ejemplares similares